Creative Medical Technology Holdings, Inc. Federal Income Tax Expense (Benefit), Continuing Operations
Creative Medical Technology Holdings, Inc. (CELZ) reported Federal Income Tax Expense (Benefit), Continuing Operations of $1.23 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-03-20
- Creative Medical Technology Holdings, Inc. federal income tax expense (benefit), continuing operations for fiscal 2025 was $1.23M, a 9.76% increase from fiscal 2024.
- Creative Medical Technology Holdings, Inc. federal income tax expense (benefit), continuing operations for fiscal 2024 was $1.12M, a 3.71% increase from fiscal 2023.
- Creative Medical Technology Holdings, Inc. federal income tax expense (benefit), continuing operations for fiscal 2023 was $1.08M, a 48.36% decline from fiscal 2022.
- Creative Medical Technology Holdings, Inc. federal income tax expense (benefit), continuing operations for fiscal 2022 was $2.10M, a 543.89% increase from fiscal 2021.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 12 month | Federal Income Tax Expense (Benefit), Continuing Operations 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.23M 10-K · filed 2026-03-20 | |
| 2024-12-31 | $1.12M 10-K · filed 2026-03-20 | |
| 2023-12-31 | $1.08M 10-K · filed 2025-03-14 | |
| 2022-12-31 | $2.10M 10-K · filed 2024-03-22 | |
| 2021-12-31 | $325.60K 10-K · filed 2023-03-31 | |
| 2020-12-31 | $250.77K 10-K · filed 2022-03-30 | |
| 2019-12-31 | $272.80K 10-K · filed 2021-03-17 | -$272.80K 10-K · filed 2020-04-06 |
| 2018-12-31 | $248.52K 10-K · filed 2020-04-06 | |
| 2017-12-31 | -$691.37K 10-K · filed 2019-04-01 | |
| 2016-12-31 | -$199.18K 10-K · filed 2018-03-29 | |
| 2015-12-31 | $0.00 10-K · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |